Aardvark Therapeutics COO Nelson Sun sells $394,957 in shares

Nelson Sun, Chief Financial & Operating Officer of Aardvark Therapeutics (NASDAQ:AARD), recently disposed of company common stock totaling $394,957 through a series of transactions. These sales occurred on September 10 and September 11, 2026.

On September 10, 2026, Mr. Sun sold 14,754 shares of common stock at a weighted-average price of $5.0006 per share. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.0007. The following day, September 11, 2026, an additional 62,000 shares were sold at a price of $5.1803 per share. The combined sales amounted to $394,957, with prices for the reported transactions ranging from $5.0006 to $5.1803.

The sales come as Aardvark’s stock trades at $5.13, down roughly 61% year-to-date. According to InvestingPro analysis, the stock appears undervalued at current levels, with the platform tracking additional insights on the company’s financial health and performance metrics.

These transactions were executed pursuant to a Rule 10b5-1 trading plan, which Mr. Sun adopted on June 11, 2026.

Following these reported sales, Mr. Sun directly holds 35,475 shares of Aardvark Therapeutics common stock. This total includes 3,745 shares acquired through the company’s 2025 Employee Stock Purchase Plan on May 22, 2026.